Abiraterone
Back to searchMolecule Structure
Scientific Name
Abiraterone
Description of the Drug
Abiraterone is an antiandrogen used in the treatment of prostate cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05812
http://www.drugbank.ca/drugs/DB05812
Brand Name(s)
Zytiga
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cytochrome P450 17A1 | SINGLE PROTEIN | INHIBITOR | CHEMBL3522 |
| Steroid 5-alpha-reductase | PROTEIN FAMILY | INHIBITOR | CHEMBL2363075 |
| Androgen Receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1871 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL61108 |
| PharmGKB | PA166123407 |
| DrugBank | DB05812 |
| PubChem: Thomson Pharma | 14925329 |
| PubChem | 132971 |
| Nikkaji | J617.457D |
| PDBe | AER |
| BindingDB | 25458 |
| EPA CompTox Dashboard | DTXSID80879993 |
| ChemicalBook | CB01320705 |
| Guide to Pharmacology | 6745 |
| rxnorm | ABIRATERONE |
| ChEBI | 68642 |
| ZINC | ZINC000003797541 |
